Dainippon Sumitomo Pharma Co Ltd is 10% Owner at Myovant Sciences Ltd. (MYOV). They have made 15 open-market trades across 1 company since 2020, most recently 2021-09-23.
15 open-market purchases totalling $38.8M since 2020, never a sale. Across 15 scored buys the stock is up 46.7% at ninety days, and 33.0 points ahead of the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MYOV | 49,936,504 | $1.3B |
Shares reported on the most recent Form 4, priced at the 2021-09-24 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 80% | 73% |
| Avg Move | +7.3% | +22.1% | +46.7% |
| Alpha | +4.2% | +16.5% | +33.0% |
| Scored | 15 | 15 | 15 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYOV | BUY | 2021-09-22 | 2021-09-24 | $22.39 | $6.2M | -15.9% | -10.6% | -30.4% |
| MYOV | BUY | 2021-09-01 | 2021-09-03 | $25.59 | $5.3M | -17.1% | -19.5% | -42.2% |
| MYOV | BUY | 2021-08-30 | 2021-09-01 | $24.00 | $4.3M | -14.0% | -12.7% | -32.8% |
| MYOV | BUY | 2021-08-18 | 2021-08-20 | $21.49 | $2.7M | +17.8% | +4.7% | -3.3% |
| MYOV | BUY | 2021-08-16 | 2021-08-18 | $21.21 | $3.0M | +13.1% | +8.0% | +1.2% |
| MYOV | BUY | 2020-05-19 | 2020-05-21 | $12.39 | $1.6M | +28.3% | +35.9% | +51.2% |
| MYOV | BUY | 2020-05-13 | 2020-05-15 | $12.24 | $1.6M | -4.5% | +34.1% | +31.5% |
| MYOV | BUY | 2020-05-11 | 2020-05-13 | $13.21 | $1.1M | +3.3% | +40.1% | +38.7% |
| MYOV | BUY | 2020-05-05 | 2020-05-07 | $11.97 | $1.2M | -6.7% | +39.4% | +25.8% |
| MYOV | BUY | 2020-04-23 | 2020-04-27 | $12.21 | $1.5M | +1.3% | +1.3% | +41.6% |
| MYOV | BUY | 2020-04-13 | 2020-04-15 | $10.41 | $1.5M | +17.6% | +16.9% | +71.6% |
| MYOV | BUY | 2020-04-07 | 2020-04-09 | $8.32 | $1.7M | +21.4% | +30.2% | +95.4% |
| MYOV | BUY | 2020-03-30 | 2020-04-01 | $7.81 | $1.1M | +50.7% | +51.9% | +180.9% |
| MYOV | BUY | 2020-03-20 | 2020-03-24 | $7.64 | $3.1M | +5.2% | +60.4% | +126.7% |
| MYOV | BUY | 2020-03-16 | 2020-03-18 | $7.33 | $2.8M | +8.8% | +51.7% | +145.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.